Investigating the hydrogen-bond acceptor site of the nicotinic pharmacophore model: A computational and experimental study using epibatidine-related molecular probes

Clelia Dallanoce, Giovanni Grazioso, Diego Yuri Pomè, Miriam Sciaccaluga, Carlo Matera, Cecilia Gotti, Sergio Fucile, Marco De Amici

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The binding mode of nicotinic agonists has been thoroughly investigated in the last decades. It is now accepted that the charged amino group is bound by a cation-π interaction to a conserved tryptophan residue, and that the aromatic moiety is projected into a hydrophobic pocket deeply located inside the binding cleft. A hydrogen bond donor/acceptor, maybe a water molecule solvating this receptor subsite, contributes to further stabilize the nicotinic ligands. The position of this water molecule has been established by several X-ray structures of the acetylcholine-binding protein. In this study, we computationally analyzed the role of this water molecule as a putative hydrogen bond donor/acceptor moiety in the agonist binding site of the three most relevant heteromeric (α4β2, α3β4) and homomeric (α7) neuronal nicotinic acetylcholine receptor (nAChR) subtypes. Our theoretical investigation made use of epibatidine 1 and deschloroepibatidine 2 as molecular probes, and was then extended to their analogues 3 and 4, which were subsequently synthesized and tested at the three target receptor subtypes. Although the pharmacological data for the new ligands 3 and 4 indicated a reduction of the affinity at the studied nAChRs with respect to reference agonists, a variation of the selectivity profile was clearly evidenced.

Original languageEnglish
Pages (from-to)975-987
Number of pages13
JournalJournal of Computer-Aided Molecular Design
Volume27
Issue number11
DOIs
Publication statusPublished - Nov 2013

Fingerprint

epibatidine
Molecular Probes
acetylcholine
Hydrogen
Hydrogen bonds
hydrogen bonds
Molecules
Water
probes
Ligands
Nicotinic Agonists
water
molecules
ligands
tryptophan
Nicotinic Receptors
Binding sites
Tryptophan
Acetylcholine
affinity

Keywords

  • Binding affinity
  • Docking
  • Epibatidine and analogues
  • Functional potency and selectivity
  • Molecular dynamics
  • Neuronal nicotinic acetylcholine receptors
  • Target-based drug design

ASJC Scopus subject areas

  • Drug Discovery
  • Physical and Theoretical Chemistry
  • Computer Science Applications

Cite this

Investigating the hydrogen-bond acceptor site of the nicotinic pharmacophore model : A computational and experimental study using epibatidine-related molecular probes. / Dallanoce, Clelia; Grazioso, Giovanni; Pomè, Diego Yuri; Sciaccaluga, Miriam; Matera, Carlo; Gotti, Cecilia; Fucile, Sergio; De Amici, Marco.

In: Journal of Computer-Aided Molecular Design, Vol. 27, No. 11, 11.2013, p. 975-987.

Research output: Contribution to journalArticle

Dallanoce, Clelia ; Grazioso, Giovanni ; Pomè, Diego Yuri ; Sciaccaluga, Miriam ; Matera, Carlo ; Gotti, Cecilia ; Fucile, Sergio ; De Amici, Marco. / Investigating the hydrogen-bond acceptor site of the nicotinic pharmacophore model : A computational and experimental study using epibatidine-related molecular probes. In: Journal of Computer-Aided Molecular Design. 2013 ; Vol. 27, No. 11. pp. 975-987.
@article{51baac3f7c844026b747cbe72129b710,
title = "Investigating the hydrogen-bond acceptor site of the nicotinic pharmacophore model: A computational and experimental study using epibatidine-related molecular probes",
abstract = "The binding mode of nicotinic agonists has been thoroughly investigated in the last decades. It is now accepted that the charged amino group is bound by a cation-π interaction to a conserved tryptophan residue, and that the aromatic moiety is projected into a hydrophobic pocket deeply located inside the binding cleft. A hydrogen bond donor/acceptor, maybe a water molecule solvating this receptor subsite, contributes to further stabilize the nicotinic ligands. The position of this water molecule has been established by several X-ray structures of the acetylcholine-binding protein. In this study, we computationally analyzed the role of this water molecule as a putative hydrogen bond donor/acceptor moiety in the agonist binding site of the three most relevant heteromeric (α4β2, α3β4) and homomeric (α7) neuronal nicotinic acetylcholine receptor (nAChR) subtypes. Our theoretical investigation made use of epibatidine 1 and deschloroepibatidine 2 as molecular probes, and was then extended to their analogues 3 and 4, which were subsequently synthesized and tested at the three target receptor subtypes. Although the pharmacological data for the new ligands 3 and 4 indicated a reduction of the affinity at the studied nAChRs with respect to reference agonists, a variation of the selectivity profile was clearly evidenced.",
keywords = "Binding affinity, Docking, Epibatidine and analogues, Functional potency and selectivity, Molecular dynamics, Neuronal nicotinic acetylcholine receptors, Target-based drug design",
author = "Clelia Dallanoce and Giovanni Grazioso and Pom{\`e}, {Diego Yuri} and Miriam Sciaccaluga and Carlo Matera and Cecilia Gotti and Sergio Fucile and {De Amici}, Marco",
year = "2013",
month = "11",
doi = "10.1007/s10822-013-9694-y",
language = "English",
volume = "27",
pages = "975--987",
journal = "Journal of Computer-Aided Molecular Design",
issn = "0920-654X",
publisher = "Springer Netherlands",
number = "11",

}

TY - JOUR

T1 - Investigating the hydrogen-bond acceptor site of the nicotinic pharmacophore model

T2 - A computational and experimental study using epibatidine-related molecular probes

AU - Dallanoce, Clelia

AU - Grazioso, Giovanni

AU - Pomè, Diego Yuri

AU - Sciaccaluga, Miriam

AU - Matera, Carlo

AU - Gotti, Cecilia

AU - Fucile, Sergio

AU - De Amici, Marco

PY - 2013/11

Y1 - 2013/11

N2 - The binding mode of nicotinic agonists has been thoroughly investigated in the last decades. It is now accepted that the charged amino group is bound by a cation-π interaction to a conserved tryptophan residue, and that the aromatic moiety is projected into a hydrophobic pocket deeply located inside the binding cleft. A hydrogen bond donor/acceptor, maybe a water molecule solvating this receptor subsite, contributes to further stabilize the nicotinic ligands. The position of this water molecule has been established by several X-ray structures of the acetylcholine-binding protein. In this study, we computationally analyzed the role of this water molecule as a putative hydrogen bond donor/acceptor moiety in the agonist binding site of the three most relevant heteromeric (α4β2, α3β4) and homomeric (α7) neuronal nicotinic acetylcholine receptor (nAChR) subtypes. Our theoretical investigation made use of epibatidine 1 and deschloroepibatidine 2 as molecular probes, and was then extended to their analogues 3 and 4, which were subsequently synthesized and tested at the three target receptor subtypes. Although the pharmacological data for the new ligands 3 and 4 indicated a reduction of the affinity at the studied nAChRs with respect to reference agonists, a variation of the selectivity profile was clearly evidenced.

AB - The binding mode of nicotinic agonists has been thoroughly investigated in the last decades. It is now accepted that the charged amino group is bound by a cation-π interaction to a conserved tryptophan residue, and that the aromatic moiety is projected into a hydrophobic pocket deeply located inside the binding cleft. A hydrogen bond donor/acceptor, maybe a water molecule solvating this receptor subsite, contributes to further stabilize the nicotinic ligands. The position of this water molecule has been established by several X-ray structures of the acetylcholine-binding protein. In this study, we computationally analyzed the role of this water molecule as a putative hydrogen bond donor/acceptor moiety in the agonist binding site of the three most relevant heteromeric (α4β2, α3β4) and homomeric (α7) neuronal nicotinic acetylcholine receptor (nAChR) subtypes. Our theoretical investigation made use of epibatidine 1 and deschloroepibatidine 2 as molecular probes, and was then extended to their analogues 3 and 4, which were subsequently synthesized and tested at the three target receptor subtypes. Although the pharmacological data for the new ligands 3 and 4 indicated a reduction of the affinity at the studied nAChRs with respect to reference agonists, a variation of the selectivity profile was clearly evidenced.

KW - Binding affinity

KW - Docking

KW - Epibatidine and analogues

KW - Functional potency and selectivity

KW - Molecular dynamics

KW - Neuronal nicotinic acetylcholine receptors

KW - Target-based drug design

UR - http://www.scopus.com/inward/record.url?scp=84890857095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890857095&partnerID=8YFLogxK

U2 - 10.1007/s10822-013-9694-y

DO - 10.1007/s10822-013-9694-y

M3 - Article

C2 - 24276616

AN - SCOPUS:84890857095

VL - 27

SP - 975

EP - 987

JO - Journal of Computer-Aided Molecular Design

JF - Journal of Computer-Aided Molecular Design

SN - 0920-654X

IS - 11

ER -